TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2
Joseph D. Trimarco(Duke University), Nicholas S. Heaton(Duke University)
Cited by 62
Related Papers
The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
|bioRxiv (Cold Spring Harbor Laboratory)|2020|63
Approaches for timeline reductions in pathogenesis studies using genetically modified mice
|Microbiology Spectrum|2023|9